We are live on !
Find out more
Aurdan Capital Management Portfolio holdings
AUM
$394M
Turnover
18.45%
1-Year Est. Return
19.7%
This Fund
S&P 500
This Quarter Est. Return
+11.98%
1 Year Est. Return
+19.7%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$394M
AUM Growth
+$61M
(+18%)
Cap. Flow
+$25.6M
Cap. Flow % of AUM
Cap. Flow %
6.48%
Top 10 Holdings %
Top 10 Hldgs %
61.98%
Holding
103
New
15
Increased
23
Reduced
49
Closed
4
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1.1
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI International Developed Markets ETF
IDEV
|
+$15.6M |
| 2 |
Fidelity Enhanced Small Cap Core ETF
FESM
|
+$10.3M |
| 3 |
Vanguard Dividend Appreciation ETF
VIG
|
+$2.45M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.3M |
| 5 |
Dimensional International Value ETF
DFIV
|
+$2.22M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Extended Market ETF
VXF
|
+$7.19M |
| 2 |
iShares Core MSCI EAFE ETF
IEFA
|
+$1.06M |
| 3 |
AutoZone
AZO
|
+$878K |
| 4 |
Medtronic
MDT
|
+$783K |
| 5 |
Cencora
COR
|
+$600K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 71.31% |
| 2 | Healthcare | 6.56% |
| 3 | Financials | 4.48% |
| 4 | Consumer Staples | 4.24% |
| 5 | Consumer Discretionary | 3.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
1
Vanguard Dividend Appreciation ETF
VIG
$116B
| $49.7M | 12.6% |
209,921
+10,652
| +5% | +$2.45M |
2024 Q4
6 quarters
|
|
2
iShares Core S&P US Growth ETF
IUSG
$32.5B
| $45.8M | 11.63% |
243,754
+1,281
| +0.5% | +$231K |
2024 Q4
6 quarters
|
|
|
3
iShares Core S&P 500 ETF
IVV
$871B
| $43.1M | 10.94% |
57,573
+3,162
| +6% | +$2.3M |
2024 Q4
6 quarters
|
|
4
Putnam Focused Large Cap Value ETF
PVAL
$15.5B
| $23.8M | 6.03% |
466,713
+35,150
| +8% | +$1.75M |
2025 Q2
4 quarters
|
|
5
Vanguard Intermediate-Term Treasury ETF
VGIT
$40.4B
| $17.6M | 4.46% |
298,048
+17,591
| +6% | +$1.04M |
2025 Q2
4 quarters
|
|
|
6
iShares Core MSCI International Developed Markets ETF
IDEV
$33.7B
| $15.7M | 3.97% |
+175,969
| New | +$15.6M |
2026 Q2
0 quarters
|
|
|
7
Dimensional International Value ETF
DFIV
$21.9B
| $14.8M | 3.76% |
274,106
+40,481
| +17% | +$2.22M |
2026 Q1
1 quarter
|
|
|
8
Vanguard Extended Market ETF
VXF
$30B
| $12.2M | 3.09% |
49,422
-31,370
| -39% | -$7.19M |
2024 Q4
6 quarters
|
|
|
9
Fidelity Enhanced Small Cap Core ETF
FESM
$6.7B
| $11.3M | 2.87% |
+234,665
| New | +$10.3M |
2026 Q2
0 quarters
|
|
10
W.W. Grainger
GWW
$64B
| $10.4M | 2.63% |
7,630
-308
| -4% | -$380K |
2024 Q4
6 quarters
|
|
11
JPMorgan Active Growth ETF
JGRO
$9.48B
| $8.68M | 2.2% |
88,063
+12,144
| +16% | +$1.15M |
2024 Q4
6 quarters
|
|
12
Philip Morris
PM
$325B
| $8.44M | 2.14% |
46,637
-1,865
| -4% | -$323K |
2024 Q4
6 quarters
|
|
13
Ross Stores
ROST
$72.9B
| $7.83M | 1.99% |
36,789
-1,859
| -5% | -$418K |
2024 Q4
6 quarters
|
|
|
14
Cencora
COR
$63.1B
| $6.82M | 1.73% |
24,097
-2,083
| -8% | -$600K |
2024 Q4
6 quarters
|
|
15
Capital Group Dividend Value ETF
CGDV
$38.9B
| $6.62M | 1.68% |
134,279
+167
| +0.1% | +$7.86K |
2024 Q4
6 quarters
|
|
16
Lowe's Companies
LOW
$117B
| $6.45M | 1.64% |
29,245
-2,129
| -7% | -$483K |
2024 Q4
6 quarters
|
|
17
Microchip Technology
MCHP
$42B
| $5.84M | 1.48% |
64,046
-2,170
| -3% | -$194K |
2024 Q4
6 quarters
|
|
18
State Street
STT
$46.2B
| $5.6M | 1.42% |
33,042
-1,515
| -4% | -$234K |
2024 Q4
6 quarters
|
|
19
Vanguard Morningstar Total Stock Market ETF
VTI
$684B
| $5.24M | 1.33% |
14,153
| – | – |
2025 Q2
4 quarters
|
|
20
Marsh
MRSH
$95.4B
| $5.21M | 1.32% |
31,289
-1,484
| -5% | -$248K |
2024 Q4
6 quarters
|
|
21
Capital Group Growth ETF
CGGR
$25.3B
| $4.73M | 1.2% |
100,144
-492
| -0.5% | -$22.2K |
2024 Q4
6 quarters
|
|
22
UnitedHealth
UNH
$365B
| $4.56M | 1.16% |
10,980
-184
| -2% | -$68.2K |
2024 Q4
6 quarters
|
|
23
Goldman Sachs ETF Trust Goldman Sachs Nasdaq-100 Premium Income ETF
GPIQ
$6.3B
| $4.5M | 1.14% |
75,821
+5,058
| +7% | +$284K |
2025 Q1
5 quarters
|
|
24
Johnson & Johnson
JNJ
$658B
| $4.39M | 1.11% |
17,300
-1,818
| -10% | -$424K |
2024 Q4
6 quarters
|
|
25
Amgen
AMGN
$252B
| $4.08M | 1.04% |
11,280
-219
| -2% | -$75K |
2024 Q4
6 quarters
|
|
Similar funds
Aurdan Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Aurdan Capital Management held 103 positions worth $394M, up 18% from $333M the previous quarter. Its ten largest holdings account for 62% of the portfolio.
Aurdan Capital Management deployed $25.6M of net new capital in Q2 2026, opening 15 new positions and adding to 23 existing holdings. Its largest new stake was iShares Core MSCI International Developed Markets ETF: 175,969 shares worth $15.7M.
By sector, the portfolio is most concentrated in Miscellaneous at 71% of assets, up from 66% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $7.19M trimmed.
- Aurdan Capital Management's largest Q2 2026 buy was iShares Core MSCI International Developed Markets ETF: 175,969 shares worth $15.7M.
- Aurdan Capital Management added most to Vanguard Dividend Appreciation ETF in Q2 2026, an estimated $2.45M increase.
- Aurdan Capital Management's biggest Q2 2026 reduction was Vanguard Extended Market ETF, cutting an estimated $7.19M.
- Aurdan Capital Management fully exited AutoZone in Q2 2026, selling an estimated $878K.
- Aurdan Capital Management's ten largest holdings make up 62% of its $394M portfolio in Q2 2026.
- Aurdan Capital Management opened 15 new positions and closed 4 in Q2 2026.
- Aurdan Capital Management's portfolio value rose 18% quarter-over-quarter to $394M.
Based on Aurdan Capital Management's 13F filing for Q2 2026, filed 15 Jul 2026.